UROPLASTY INC 4
4 · UROPLASTY INC · Filed Apr 2, 2015
Insider Transaction Report
Form 4
Hammers Darin
Sr VP Global Sales & Marketing
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2015-03-31−100,000→ 0 totalExercise: $2.69Exp: 2020-02-10→ Common Stock (100,000 underlying) - Disposition to Issuer
Common Stock
2015-03-31−131,800→ 0 total
Footnotes (2)
- [F1]Consists of 33,333 shares subject to restricted stock assumed by Cogentix Medical, Inc., formerly Vision-Sciences, Inc. ("Cogentix") in the merger agreement between issuer and Cogentix and replaced with 24,219 shares of Cogentix stock valued at $4.09 per share, 75,000 shares subject to restricted stock assumed by Cogentix and replaced with 54,495 shares of Cogentix stock valued at $4.56 per share and 23,467 shares disposed of pursuant to the merger agreement in exchange for 17,052 shares of Cogentix common stock on the effective date of the merger.
- [F2]This option, which provided for vesting in three almost equal annual installments beginning on February 11, 2014, was assumed by Cogentix in the merger and replaced with an option to purchase 72,661 shares of Cogentix stock for $3.71 per share.